Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease
$2,595,120RF1FY2020AGNIH
Rensselaer Polytechnic Institute, Troy NY
Investigators
Linked publications & trials
Paper 38849023Paper 38786623Paper 38612775Paper 37306476Paper 37235665Paper 37014788Paper 36878848Paper 36876791Paper 36725112Paper 36589242Paper 36551220Paper 36419932Paper 36358923Paper 36046608Paper 35463198Paper 35288626Paper 35287864Paper 35255395Paper 35229716Paper 35143487Paper 35108013Paper 35107975Paper 34699015Paper 34351732Paper 34095227Paper 33580179
Abstract
Neurofibrillary tangles (NFT) is a pathological hallmark of Alzheimer?s disease (AD). NFT is composed of aggregated tau protein and is correlated to cognitive decline in dementia progression. NFT spreads in the brain in a prion-like manner, mediated by the interaction between tau and neuronal surface glycans. The long-term goal is to study the structural details of tau-glycan interaction and to discover drugs to disrupt this interaction for disease-modifying treatment of AD. In this proposal, we will study the tau-heparan sulfate interaction from at the molecular (aim 1), the cellular (aim 2), and organismal level and carry out drug discovery (aim 3).
View original record on NIH RePORTER →